Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Harvard Business School
Moodys
Merck
Dow

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Litigation Details for Acorda Therapeutics Inc. v. Alkem Laboratories Ltd. (D. Del. 2014)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Acorda Therapeutics Inc. v. Alkem Laboratories Ltd. (D. Del. 2014)

Docket   Start Trial Date Filed 2014-07-11
Court District Court, D. Delaware Date Terminated 2016-08-05
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties ACORDA THERAPEUTICS INC.; ALKEM LABORATORIES LTD.; ALKERMES PHARMA IRELAND LIMITED; ASCEND LABORATORIES LLC
Patents 5,540,938; 8,007,826; 8,354,437; 8,440,703; 8,663,685
Attorneys Aaron Stiefel; Daniel P. DiNapoli; Jack B. Blumenfeld; Jeffrey Martin; John C. Phillips , Jr.; Maryellen Noreika; Soumitra Deka
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Acorda Therapeutics Inc. v. Alkem Laboratories Ltd.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Acorda Therapeutics Inc. v. Alkem Laboratories Ltd. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-07-11 1 Defendants for patent infringement of United States Patent Nos. 5,540,938 (the “’938 patent”), 8,007,8268,007,826 (the “’826 patent”), 8,354,437 (the “’437 patent”), 8,440,703 (the “’703 patent”) and 8,663,685 (the… patent, ’703 patent, and ’685 patent, and the right to sue for infringement thereof. 7. …the ’938 patent. A copy of the ’938 patent is attached hereto as Exhibit A. The ’826 Patent 25… for the ’938 patent as July 30, 2018, the ’826 patent as May 26, 2027, the ’437 patent as December 22 External link to document
2016-08-05 29 States Patent Nos. 5,540,938, 8,077,826. 8.354,437, 8,440,703 , and 8.663,685 (the "Patents"…CONSENT JUDGMENT WHEREAS. this action for patent infringement has been brought by Plaintiffs Acorda…all proper in this Court. 2. The Patents are enforceable and valid. Case 1:14-cv-00917-LPS…353 3. Alkem has infringed the Patents pursuant to 35 U.S.C. §271(e)(2) by filing Abbreviated…any of its Affiliates, until the license to the Patents provided in the Settlement Agreement becomes External link to document
2014-07-11 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,540,938; 8,007,826; 8,354,437…2014 5 August 2016 1:14-cv-00917 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Express Scripts
Boehringer Ingelheim
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.